Insider · CIK 0001534264
Eli Casdin
Files at BLFS (BIOLIFE SOLUTIONS INC), LAB (STANDARD BIOTOOLS INC.), WGS (GeneDx Holdings Corp.), SLGC (SomaLogic, Inc.), EQRX (EQRx, Inc.), TSVT (2seventy bio, Inc.). First filing -, latest -.
In brief
Eli Casdin files SEC Form 4 as director and 10% owner at BLFS (BIOLIFE SOLUTIONS INC), and also at LAB (STANDARD BIOTOOLS INC.), WGS (GeneDx Holdings Corp.), SLGC (SomaLogic, Inc.), EQRX (EQRx, Inc.) and 1 more. No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Eli Casdin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 50 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +3,576 | $0.00 | $0 | 24,093 | Jun 23, 2026 |
| Jun 18, 2026 | LAB STANDARD BIOTOOLS INC. | AGrant or award Common Stock | +99,116 | $0.00 | $0 | 3,053,169 | Jun 23, 2026 |
| Jun 18, 2026 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +4,248 | $0.00 | $0 | 4,248 | Jun 23, 2026 |
| Jun 18, 2026 | LAB STANDARD BIOTOOLS INC. | AGrant or award Stock Option (Right to buy)derivative | +175,923 | $0.00 | $0 | 175,923 | Jun 23, 2026 |
| Jun 18, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -3,576 | $0.00 | $0 | 0 | Jun 23, 2026 |
| Feb 26, 2026 | LAB STANDARD BIOTOOLS INC. | AGrant or award Common Stock | +52,991 | $1.17 | $62k | 2,954,053 | Mar 2, 2026 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +12,924 | $0.00 | $0 | 20,518 | Aug 7, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +3,576 | $0.00 | $0 | 3,576 | Aug 7, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -12,924 | $0.00 | $0 | 0 | Aug 7, 2025 |
| Jun 20, 2025 | LAB STANDARD BIOTOOLS INC. | AGrant or award Common Stock | +94,592 | $0.00 | $0 | 2,901,062 | Jun 24, 2025 |
| Jun 20, 2025 | LAB STANDARD BIOTOOLS INC. | AGrant or award Stock Option (Right to buy)derivative | +125,660 | $0.00 | $0 | 125,660 | Jun 24, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +12,924 | $0.00 | $0 | 20,518 | Jun 23, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +3,576 | $0.00 | $0 | 3,576 | Jun 23, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -12,924 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Jul 19, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Common Stock | +1,588 | $0.00 | $0 | 2,752,332 | Jul 23, 2024 |
| Jun 28, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Common Stock | +43,128 | $0.00 | $0 | 2,750,744 | Jul 2, 2024 |
| Jun 28, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Stock Option (Right to buy)derivative | +72,213 | $0.00 | $0 | 72,213 | Jul 2, 2024 |
| Jun 26, 2024 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +12,924 | $0.00 | $0 | 12,924 | Jun 27, 2024 |
| Jun 20, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +5,828 | $0.00 | $0 | 7,593 | Jun 24, 2024 |
| Jun 20, 2024 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -5,828 | $0.00 | $0 | 0 | Jun 24, 2024 |
| Feb 20, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Common Stock | +22,800 | $2.50 | $57k | 103,556 | Feb 22, 2024 |
| Jan 5, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Common Stock | +3,807 | - | - | 76,949 | Jan 9, 2024 |
| Jan 5, 2024 | SLGC SomaLogic, Inc. | DDisposition to issuer Common Stock | -3,430 | - | - | 0 | Jan 9, 2024 |
| Jan 5, 2024 | SLGC SomaLogic, Inc. | DDisposition to issuer Common Stockindirect: By CMLS Holdings II LLC | -6,800,000 | - | - | 0 | Jan 9, 2024 |
| Jan 5, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Common Stock | +3,807 | - | - | 80,756 | Jan 9, 2024 |
| Jan 5, 2024 | SLGC SomaLogic, Inc. | DDisposition to issuer Common Stockindirect: By Casdin Master Fund, L.P. | -10,132,005 | - | - | 0 | Jan 9, 2024 |
| Jan 5, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Common Stockindirect: By CMLS Holdings II LLC | +7,548,000 | - | - | 7,548,000 | Jan 9, 2024 |
| Jan 5, 2024 | SLGC SomaLogic, Inc. | DDisposition to issuer Common Stockindirect: By Casdin Private Growth Equity Fund, L.P. | -2,472,270 | - | - | 0 | Jan 9, 2024 |
| Jan 5, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Common Stockindirect: By Casdin Partners Master Fund, L.P. | +11,246,525 | - | - | 11,246,525 | Jan 9, 2024 |
| Jan 5, 2024 | SLGC SomaLogic, Inc. | DDisposition to issuer Stock Option (Right to buy)derivative | -41,905 | - | - | 0 | Jan 9, 2024 |
| Jan 5, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Common Stockindirect: By Casdin Private Growth Equity Fund, L.P. | +2,744,219 | - | - | 2,744,219 | Jan 9, 2024 |
| Jan 5, 2024 | SLGC SomaLogic, Inc. | DDisposition to issuer Stock Option (Right to buy)derivative | -46,705 | - | - | 0 | Jan 9, 2024 |
| Jan 5, 2024 | SLGC SomaLogic, Inc. | DDisposition to issuer Stock Option (Right to buy)derivative | -20,600 | - | - | 0 | Jan 9, 2024 |
| Jan 5, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Stock Option (Right to buy)derivative | +51,842 | - | - | 51,842 | Jan 9, 2024 |
| Jan 5, 2024 | SLGC SomaLogic, Inc. | DDisposition to issuer Stock Option (Right to buy)derivative | -20,600 | - | - | 0 | Jan 9, 2024 |
| Jan 5, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Stock Option (Right to buy)derivative | +22,866 | - | - | 22,866 | Jan 9, 2024 |
| Jan 5, 2024 | SLGC SomaLogic, Inc. | DDisposition to issuer Restricted Stock Unitderivative | -3,430 | - | - | 0 | Jan 9, 2024 |
| Jan 5, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Stock Option (Right to buy)derivative | +22,866 | - | - | 22,866 | Jan 9, 2024 |
| Jan 5, 2024 | SLGC SomaLogic, Inc. | DDisposition to issuer Warrant to purchase common stock (Right to buy)derivativeindirect: By CMLS Holdings II LLC | -4,346,669 | - | - | 0 | Jan 9, 2024 |
| Jan 5, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Stock Option (Right to buy)derivative | +46,514 | - | - | 46,514 | Jan 9, 2024 |
| Jan 5, 2024 | LAB STANDARD BIOTOOLS INC. | AGrant or award Warrant to purchase common stock (Right to buy)derivativeindirect: CMLS Holdings LLC | +4,824,802 | - | - | 4,824,802 | Jan 9, 2024 |
| Nov 9, 2023 | EQRX EQRx, Inc. | JOther Common Stockindirect: See footnote | -8,659,372 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 9, 2023 | EQRX EQRx, Inc. | JOther Common Stockindirect: See footnote | -30,214,934 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 9, 2023 | EQRX EQRx, Inc. | JOther Common Stockindirect: See footnote | -3,824,572 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 9, 2023 | EQRX EQRx, Inc. | JOther Common Stockindirect: See footnote | -5,488,164 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 9, 2023 | EQRX EQRx, Inc. | JOther Warrants to purchase Class A Common Stock (right to buy)derivativeindirect: See footnote | -8,110,001 | $0.00 | $0 | 0 | Nov 14, 2023 |
| Nov 9, 2023 | EQRX EQRx, Inc. | JOther Earn-out Sharesderivativeindirect: See footnote | -3,472,300 | - | - | 0 | Nov 14, 2023 |
| Nov 9, 2023 | EQRX EQRx, Inc. | JOther Earn-out Sharesderivativeindirect: See footnote | -526,674 | - | - | 0 | Nov 14, 2023 |
| Nov 9, 2023 | EQRX EQRx, Inc. | JOther Earn-out Sharesderivativeindirect: See footnote | -755,766 | - | - | 0 | Nov 14, 2023 |
| Nov 9, 2023 | EQRX EQRx, Inc. | JOther Stock Option (Right to Buy)derivative | -101,010 | $0.00 | $0 | 0 | Nov 14, 2023 |
Questions about Eli Casdin
Answered from the filings on this page, as of the latest one.
Is Eli Casdin buying or selling?
Eli Casdin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Eli Casdin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eli Casdin has 0.
Where does Eli Casdin file Form 4?
Eli Casdin has filed Form 4 at BLFS (BIOLIFE SOLUTIONS INC); LAB (STANDARD BIOTOOLS INC.); WGS (GeneDx Holdings Corp.); SLGC (SomaLogic, Inc.); EQRX (EQRx, Inc.) and 1 more. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.